BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3518967)

  • 1. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of HRE 664, a penem antibiotic.
    Chin XN; Neu HC
    Diagn Microbiol Infect Dis; 1990; 13(6):509-16. PubMed ID: 2279381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.
    Neu HC; Chin NX; Huang HB
    Antimicrob Agents Chemother; 1993 Mar; 37(3):566-73. PubMed ID: 8460925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
    Chin NX; Zhang YX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
    Neu HC; Novelli A; Chin NX
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1009-18. PubMed ID: 2789493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
    Chin NX; Gu JW; Fang W; Neu HC
    Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
    Wise R; Cross C; Andrews JM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC; Chin NX; Jules K; Labthavikul P
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165.
    Neu HC; Chin NX
    Antimicrob Agents Chemother; 1987 Apr; 31(4):505-11. PubMed ID: 3300528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
    Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
    Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity and beta-lactamase stability of LJC 10,627.
    Neu HC; Gu JW; Fang W; Chin NX
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.